SCHEMBL6985319

SCHEMBL6985319

O=S(=O)(Nc1ccc2c(c1)CCCN2)c1ccc(Br)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CA9 Q16790 1/20 0.53
ESR1 P03372 1/20 0.51
PKM P14618 2/20 0.51
LMNA P02545 3/20 0.50
ALDH1A1 P00352 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
THRB P10828 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
IDO1 P14902 2/20 0.49
TP53 P04637 1/20 0.46
MAPT P10636 1/20 0.46
HTR6 P50406 1/20 0.46
HSD17B2 P37059 1/20 0.46
POLB P06746 1/20 0.45
HDAC3 O15379 1/20 0.45
HDAC4 P56524 1/20 0.45
HDAC1 Q13547 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6982218 0.87 PKM (0.56) CA12CA1CA2CA9ESR1
SCHEMBL6985107 0.87 LMNA (0.67) CA12CA1CA2CA9ESR1
SCHEMBL6986758 0.87 PKM (0.56) CA12CA1CA2CA9ESR1
SCHEMBL6984820 0.87 HTR6 (0.61) CA12CA1CA2CA9PKM
SCHEMBL6974134 0.86 HSD17B2 (0.50) CA12CA1CA2CA9PKM
SCHEMBL31681377 0.85 EIF2AK2 (0.54) CA12CA1CA2CA9PKM
SCHEMBL6976538 0.81 PKM (0.65) CA12CA1CA2CA9PKM
SCHEMBL18553725 0.81 LMNA (0.69) ESR1PKMLMNAALDH1A1SMN1; SMN2
SCHEMBL2283294 0.80 CA1 (0.60) CA12CA1CA2CA9PKM
SCHEMBL6983859 0.79 PKM (0.56) PKMLMNATP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed